Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands

Saved in:
Bibliographic Details
Published in:Infectious Diseases and Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1871837825044840450
collection WordPress RSS
FRELIP Feed Integration
container_title Infectious Diseases and Therapy
description
discipline_display Communicable Diseases, Epidemiology
discipline_facet Communicable Diseases, Epidemiology
format Online Article
RSS Article
genre Journal Article
id rss_article:106424
institution FRELIP
journal_source_facet Infectious Diseases and Therapy
last_indexed 2026-07-27T03:40:58.044Z
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
sub_discipline_display General
sub_discipline_facet General
subject_display Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
subject_facet Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
title Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_alt Costo-efectividad de la vacuna bivalente de prefusión F contra el virus sincitial respiratorio para adultos mayores en los Países Bajos
Rentabilité du vaccin bivalent à protéine F de préfusion du virus respiratoire syncytial pour les personnes âgées aux Pays-Bas
Custo-Efetividade da Vacina Bivalente de Proteína F de Pré-Fusão do Vírus Sincicial Respiratório para Adultos Mais Velhos na Holanda
title_auth Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_es_txt Costo-efectividad de la vacuna bivalente de prefusión F contra el virus sincitial respiratorio para adultos mayores en los Países Bajos
title_fr_txt Rentabilité du vaccin bivalent à protéine F de préfusion du virus respiratoire syncytial pour les personnes âgées aux Pays-Bas
title_full Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_fullStr Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_full_unstemmed Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_pt_txt Custo-Efetividade da Vacina Bivalente de Proteína F de Pré-Fusão do Vírus Sincicial Respiratório para Adultos Mais Velhos na Holanda
title_short Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Prefusion F Vaccine for Older Adults in the Netherlands
title_sort cost-effectiveness of bivalent respiratory syncytial virus prefusion f vaccine for older adults in the netherlands
topic Communicable Diseases, Epidemiology
General
Communicable Diseases, Epidemiology
url https://link.springer.com/article/10.1007/s40121-026-01400-w